Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Ramping up vtm production

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Jan 05, 2022 12:28pm

123 Views

Post# 34285620

RE:RE:RE:RE:RE:RE:Ramping up vtm production

For sure it is, completing the automation projects as soon as possible is the key to unlocking all of this potentital business. They know that and sounds like it's going well so far. Once it's done it sounds like they have the customers lining up for both. If they can pull off a Kinlytic deal as well it will be a very, very good year.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing